Skip to main content
SpringerLink
Log in

Prevention of corticosteroid-induced osteoporosis

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996 Nov; 39(11): 1791–801

    Article  Google Scholar 

  2. Adachi JD, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997 Aug 7; 337: 382–7

    Article  PubMed  CAS  Google Scholar 

  3. Reid IR. Preventing glucocorticoid-induced osteoporosis. N Engl J Med 1997 Aug 7; 337: 420–1

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prevention of corticosteroid-induced osteoporosis. Drugs Ther. Perspect 10, 10 (1997). https://doi.org/10.2165/00042310-199710080-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199710080-00003

Keywords

Search

Navigation